NEURIZON Trademark
Trademark Overview
On Monday, October 28, 2024, a trademark application was filed for NEURIZON with the United States Patent and Trademark Office. The USPTO has given the NEURIZON trademark a serial number of 79410014. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 21, 2024. This trademark is owned by PharmAust Limited. The NEURIZON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development services of new pharmaceutical products; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical testing; pharmaceutical product evaluation; providing information about the results of clinical trials for pharmaceuticals; biological, clinical and medical research; consultancy relating to research and development in the field of therapeutics; conducting clinical trials; providing information and data relating to medical and veterinary research and development; providing information relating to medical research in the field of veterinary pharmacovigilance; veterinary research; veterinary laboratory services; scientific research for medical purposes in the field of cancerous diseases; drug development services.
General Information
| Serial Number | 79410014 |
| Word Mark | NEURIZON |
| Filing Date | Monday, October 28, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development services of new pharmaceutical products; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical testing; pharmaceutical product evaluation; providing information about the results of clinical trials for pharmaceuticals; biological, clinical and medical research; consultancy relating to research and development in the field of therapeutics; conducting clinical trials; providing information and data relating to medical and veterinary research and development; providing information relating to medical research in the field of veterinary pharmacovigilance; veterinary research; veterinary laboratory services; scientific research for medical purposes in the field of cancerous diseases; drug development services. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 21, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | PharmAust Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
Trademark Events
| Event Date | Event Description |
| Thursday, November 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 22, 2024 | APPLICATION FILING RECEIPT MAILED |
